Presseportal: Abbott Laboratories - Abbott meldet Aufhebung des ...
Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily
chemie.pr-rss.com
08.08.2008 01:00:07
Abbott Laboratories: Mexico City (ots/PRNewswire) - - Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review Abbott (NYSE: ABT) presented pivotal data at the XVII International AIDS Conference ...
Lesen Sie hier weiter... |
Drucken |
PDF
Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily
Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule.Abbott Laboratories: Mexico City (ots
Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily
Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily
Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule Mexico City (ots/PRNewswire) - - Pivotal